Spherically symmetric mesenchymal stromal cell bodies inherent with endogenous extracellular matrices for cellular cardiomyoplasty

Stem Cells

Volumn 27, Issue 3, 2009, Pages 724-732

  Wang, Chung Chi ^a,c   Chen, Chun Hung ^d   Hwang, Shiaw Min ^e   Lin, Wei Wen ^b   Huang, Chih Hao ^d   Lee, Wen Yu ^d   Chang, Yen ^a,b,c   Sung, Hsing Wen ^d  

^a Department of Surgery   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^e FOOD INDUSTRY RESEARCH AND DEVELOPMENT INSTITUTE   (Taiwan)

Author keywords

Angiogenesis; Cell body; Cell therapy; Cell transplantation; Myocardial infarction

Indexed keywords

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPLASTY; CELL ADHESION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSPLANTATION; CELL TRANSPORT; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EXTRACELLULAR MATRIX; HEART CATHETERIZATION; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HYDROGEL; MALE; MESENCHYME CELL; NONHUMAN; RAT; STROMA CELL;

ANIMALS; CARDIOMYOPLASTY; CELLS, CULTURED; ECHOCARDIOGRAPHY; EXTRACELLULAR MATRIX; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MYOCARDIAL INFARCTION; RATS; RATS, INBRED LEW; STROMAL CELLS; VENTRICULAR FUNCTION, LEFT;

RATTUS;

EID: 65249111036     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2008-0944     Document Type: Article

References (38)

1. Ryu JH, Kim IK, Cho SW et al. Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances neovascularization in infracted myocardium. Biomaterials 2005;26:319-326.
2. Perin EC, Dohmann HF, Borojevic R et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemicheart failure. Circulation 2003;107:2294-2302.
3. Memon IA, Sawa Y, Fukushima N et al. Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets. J Thorac Cardiovasc Surg 2005;130:1333-1341.
4. Teng CJ, Luo J, Chiu RC et al. Massive mechanical loss of microspheres with direct intramyocardial injection in the beating heart: Implications for cellular cardiomyoplasty. J Thorac Cardiovasc Surg 2006;132:628-632.
5. Reinecke H, Zhang M, Bartosek T et al. Survival, integration, and differentiation of cardiomyocyte grafts: A study in normal and injuredrat hearts. Circulation 1999;100:193-202.
6. Engel J, Hilgard P, inventors; Asta Medica Aktiengellschaft, assignee. Long-acting injection suspensions and a process for their preparation. US patent 5 773 032. June 30, 1998.
7. Yan C, Li X, Chen X et al. Anticancer gelatin microspheres with multiple function. Biomaterials 1991;12:640-644.
8. Urbanek K, Rota M, Cascapera S et al. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res 2005;97:663-673.
9. Yang MJ, Chen CH, Lin PJ et al. Novel method of forming human embryoid bodies in a polystyrene dish surface-coated with a temperatureresponsive methylcellulose hydrogel. Biomacromolecules 2007;8:2746-2752.
10. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1999;276:71-74.
11. Horwitz EM, Prockop DJ, Fitzpatrick LA et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999;5:309-313.
12. Horwitz EM, Gordon PL, Koo WK et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci USA 2002;99:8932-8937.
13. Amado LC, Saliaris AP, Schuleri KH et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA 2005;102:11474-11479.
14. Janssens S, Dubois C, Bogaert J et al. Autologous bone marrowderived stem-cell transfer in patients with ST-segment elevation myocardial infarction: Double-blind, randomised controlled trial. Lancet 2006;367:113-121.
15. Chen CH, Chang Y, Wang CC et al. Construction and characterization of fragmented mesenchymal-stem-cell sheets for intramuscular injection. Biomaterials 2007;28:4643-4651.
16. Wei HJ, Chen SC, Chang Y et al. Porous acellular bovine pericardia seeded with mesenchymal stem cells as a patch to repair a myocardial defect in a syngeneic rat model. Biomaterials 2006;27:5409-5419.
17. Chang Y, Lai PH, Wei HJ et al. Tissue regeneration observed in a basic fibroblast growth factor-loaded porous acellular bovine pericardium populated with mesenchymal stem cells. J Thorac Cardiovasc Surg 2007;134:65-73.
18. Tomita S, Li RK, Weisel RD et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 1999;100(19,suppl): II247-II256.
19. Fukuda J, Khademhosseini A, Yeo Y et al. Micromolding of photocrosslinkable chitosan hydrogel for spheroid microarray and co-cultures. Biomaterials 2007;27:5259-5267.
20. Nagaya N, Fujii T, Iwase T et al. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol 2004;287:2670-2676.
21. Hida N, Nishiyama N, Miyoshi S et al. Novel cardiac precursor-like cells from human menstrual blood-derived mesenchymal cells. Stem Cells 2008;26:1695-1704.
22. Toma C, Pittenger MF, Cahill KS et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002;105:93-98.
23. Davani S, Marandin A, Mersin N et al. Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model. Circulation 2003;108(suppl I):II253-II258.
24. Hsieh PC, MacGillivray C, Gannon J et al. Local controlled intramyocardial delivery of platelet-derived growth factor improves postinfarction ventricular function without pulmonary toxicity. Circulation 2006; 114:637-644.
25. Dai W, Hale SL, Martin BJ et al. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: Short- and long-term effects. Circulation 2005;112:214-223.
26. Krupnick AS, Kreisel D, Engels FH et al. A novel small animal model of left ventricular tissue engineering. J Heart Lung Transplant 2002; 21:233-243.
27. Christman KL, Lee RJ. Biomaterials for the treatment of myocardial infarction. J Am Coll Cardiol 2006;48:907-913.
28. Shen M, Horbett TA. The effects of surface chemistry and adsorbed proteins on monocyte/macrophage adhesion to chemically modified polystyrene surfaces. J Biomed Mater Res 2001;57:336-345.
29. Potapova IA, Gaudette GR, Brink PR et al. Mesenchymal stem cells support migration, extracellular matrix invasion, proliferation, and survival of endothelial cells in vitro. Stem Cells 2007;25:1761-1768.
30. Rosova I, Dao M, Capoccia B et al. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 2008;26:2173-2182.
31. Annabi B, Lee YT, Turcotte S et al. Hypoxia promotes murine bonemarrow-derived stromal cell migration and tube formation. Stem Cells 2003;21:337-347.
32. Sottile J, Hocking DC, Swiatek PJ. Fibronectin matrix assembly enhances adhesion-dependent cell growth. J Cell Sci 1998;111:2933- 2943.
33. Mercurius KW, Morla AO. Inhibition of vascular smooth muscle cell growth by inhibition of fibronectin matrix assembly. Circ Res 1998 82:548-556.
34. Chen CH, Wei HJ, Lin WW et al. Porous tissue grafts sandwiched with multilayered mesenchymal stromal cell sheets induce tissue regeneration for cardiac repair. Cardiovasc Res 2008;80:88-95.
35. Kinnaird T, Stabile E, Burnett MS et al. Bone marrow-derived cells for enhancing collateral development mechanisms, animal data, and initial clinical experiences. Circ Res 2004;95:354-363.
36. Wu Y, Chen L, Scott PG et al. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 2007;25:2648-2659.
37. Boyle AJ, Schulman SP, Hare JM et al. Is stem cell therapy ready for patients? Stem cell therapy for cardiac repair ready for the next step. Circulation 2006;114:339-352.
38. Murry CE, Reinecke H, Pabon LM. Regeneration gaps: Observations on stem cells and cardiac repair. J Am Coll Cardiol 2006;47:1777-1785.